Filtered By:
Specialty: Pharmaceuticals

This page shows you your search results in order of date.

Order by Relevance | Date

Total 210 results found since Jan 2013.

Cases of Pediatric Therapeutic Errors Related to ADHD Meds on the Rise
MONDAY, Sept. 18, 2023 -- From 2000 to 2021, there was an almost 300 percent increase in the annual frequency of cases of pediatric out-of-hospital therapeutic errors related to attention-deficit/hyperactivity disorder (ADHD) medications, according...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

ADHD Is Independent Risk Factor for Psychiatric Disorders
THURSDAY, Sept. 7, 2023 -- Attention-deficit hyperactivity disorder (ADHD) is an independent risk factor for certain psychiatric disorders, including anorexia nervosa and major depressive disorder, according to a study published online Sept. 5 in...
Source: Drugs.com - Pharma News - September 7, 2023 Category: Pharmaceuticals Source Type: news

Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
DUBLIN, Aug. 31, 2023 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced that its Specialty Generics segment, operating as SpecGx LLC, received approval on August 25, ... Biopharmaceuticals, Generics, FDA Mallinckrodt, SpecGx, lisdexamfetamine, ADHD
Source: HSMN NewsFeed - August 31, 2023 Category: Pharmaceuticals Source Type: news

Generics of Vyvanse, Takeda's ADHD drug, get FDA green light
Takeda Pharmaceutical Company Limited just lost exclusivity on its ADHD drug.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 28, 2023 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

Output of ADHD Meds Needs Boosting
WEDNESDAY, Aug. 2, 2023 -- While demand for prescription stimulants is surging, a shortage of the drugs persists, so federal officials have stepped in and asked drug companies to ramp up production of the medications. Officials from both the U.S....
Source: Drugs.com - Pharma News - August 2, 2023 Category: Pharmaceuticals Source Type: news

Amid Shortages, Federal Agencies Ask Drugmakers to Boost Output of ADHD Meds
WEDNESDAY, Aug. 2, 2023 -- While demand for prescription stimulants is surging, a shortage of the drugs persists, so federal officials have stepped in and asked drug companies to ramp up production of the medications. Officials from both the U.S....
Source: Drugs.com - Pharma News - August 2, 2023 Category: Pharmaceuticals Source Type: news

Stimulant Treatment for Childhood ADHD Not Linked to Substance Use
TUESDAY, July 11, 2023 -- For children with attention-deficit/hyperactivity disorder (ADHD), stimulant treatment is not associated with later frequent substance use by adolescents and young adults, according to a study published online July 5 in...
Source: Drugs.com - Pharma News - July 11, 2023 Category: Pharmaceuticals Source Type: news

There Is No Evidence That Links ADHD Meds To Substance Use Disorder
A new study says taking ADHD medicines like methylphenidate during childhood are not associated with substance use disorders in early adulthood.
Source: Forbes.com Healthcare News - July 5, 2023 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news

Stop-Signal Task May Aid Assessment of Adult ADHD
FRIDAY, June 16, 2023 -- The stop-signal task may be valuable for assessing inhibitory control deficits in adult attention-deficit/hyperactivity disorder (ADHD), according to a systematic review and meta-analysis published online June 10 in...
Source: Drugs.com - Pharma News - June 16, 2023 Category: Pharmaceuticals Source Type: news

Taking ‘Smart Drugs’ Like Adderall Without ADHD Actually Decreases Productivity–Here’s How
Using ADHD drugs when you don ’t have it may make you work more—but less successfully.
Source: Forbes.com Healthcare News - June 14, 2023 Category: Pharmaceuticals Authors: Darreonna Davis, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Breaking breaking-news topline Source Type: news

Employers see the positive side of ADHD and autism
Recognition grows of the beneficial qualities of neurodiverse conditions
Source: FT.com - Drugs and Healthcare - May 26, 2023 Category: Pharmaceuticals Source Type: news

We’ve all got ADHD symptoms. Right?
New focus on the diagnosis of this bewildering condition has left us even more confused 
Source: FT.com - Drugs and Healthcare - May 19, 2023 Category: Pharmaceuticals Source Type: news

Most Children With ADHD Are Not Receiving Medications
FRIDAY, April 28, 2023 -- Most children with parent-reported attention-deficit/hyperactivity disorder (ADHD) are not receiving medications and have never received outpatient mental health care, according to a study published online April 28 in JAMA...
Source: Drugs.com - Pharma News - April 28, 2023 Category: Pharmaceuticals Source Type: news

ADHD Tied to Higher Fracture Risk in Children
MONDAY, April 24, 2023 -- Children with attention-deficit/hyperactivity disorder (ADHD) have higher risk of fractures than matched children without ADHD, according to a study published April 1 in the European Journal of Pediatrics. Tomer...
Source: Drugs.com - Pharma News - April 24, 2023 Category: Pharmaceuticals Source Type: news

Stimulant Misuse Rates Higher in Schools With More Students With Prescriptions
TUESDAY, April 18, 2023 -- Risk for nonmedical use of prescription stimulants (NUPS) is higher for schools with a greater proportion of the student body that uses stimulant therapy for attention-deficit/hyperactivity disorder (ADHD), according to a...
Source: Drugs.com - Pharma News - April 18, 2023 Category: Pharmaceuticals Source Type: news